Skylight Health Group Inc

Skylight Health Group, Inc. is a healthcare services and technology company that works to impact patient health outcomes. The firm operates a United States health network that comprises of physical multi-disciplinary medical clinics providing a range of services from primary care, sub-specialty, allied health and laboratory & diagnostic testing. It owns and operates a proprietary electronic health record system that supports the delivery of care to patients via telemedicine and other remote monitoring system integrations. The company primarily operates an insurable fee-for-service model contracting with Medicare, Medicaid and other commercial payors. It also offers a disruptive subscription-based telemedicine service for the un & under-insured population who have limited access to urgent care due to cost. The company was founded by Pradyum Sekar and Kashaf Qureshi in 2014 and is headquartered in Mississauga, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Toronto, Ontario--(Newsfile Corp. - August 30, 2023) - Skylight Health Group Inc. (TSXV: SLHG) (OTC Pink: SLHGF) ("Skylight Health" or the "Company") and its subsidiaries (collectively, the "Skylight Group") announces today: (i) updates on the Company's strategy following the completion of the previously announced enforcement and settlement transactions; and (ii) the resignation of certain officers of the Company. As previously announced, in July 2023 the Company and its affiliates completed transactions (the "Enforcement and Settlement Transactions") with their secured lenders, Families-Backing-Families Credit Fund I, LP ("FLC") and Walleye Opportunities Master Fund Ltd.

Skylight Health Announces Management Changes and Updates Following Previously Announced Enforcement and Settlement Transactions

Toronto, Ontario--(Newsfile Corp. - July 19, 2023) - Skylight Health Group Inc. (TSXV: SLHG) (OTCQX: SLHGF) ("Skylight Health" or the "Company") and its subsidiaries (collectively, the "Skylight Group") announce today the completion of transactions (the "Enforcement and Settlement Transactions") with their secured lenders, Families-Backing-Families Credit Fund I, LP ("FLC") and Walleye Opportunities Master Fund Ltd. ("Walleye") and the orderly wind down of remaining US operations.

Skylight Health Announces Foreclosure and Settlement Transactions For US Operations

TORONTO, May 01, 2023 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SLHG; OTCQX:SLHGF) ("Skylight Health" or the "Company") announces today that the Company does not expect to be in a position to complete its year-end audit and complete and file its annual financial statements and related management discussion and analysis for the 2022 financial year and, as a result, the Ontario Securities Commission may issue a cease trade order against the company restricting trade in the securities of the Company.

Skylight Health Announces Delay in Filing

TORONTO, April 03, 2023 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SLHG; OTCQX:SLHGF) (“Skylight Health” or the “Company”) today announces that Patrick McNamee has resigned from the Company's Board of Directors, effective March 31, 2023 to pursue other opportunities. Mr. McNamee had served as the Company's Chairman of the Board since his appointment in March 2021.

Skylight Health Announces Resignation of Board Member

TORONTO, March 16, 2023 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SLHG; OTCQX:SLHGF) (“Skylight Health” or the “Company”); a healthcare platform combining technology, and analytics focused on transitioning patients into value-based care to drive better health outcomes and experiences in the United States, today announced that its Board of Directors has suspended the payment of dividends on the Company's 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares (the “Series A Preferred Shares”) until further notice. The Series A Preferred Shares trade under the “SLHGP” stock ticker symbol.

Skylight Health Suspends Series A Preferred Stock Cash Dividend

TORONTO, Jan. 20, 2023 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SLHG; OTCQX: SLHGF) (“Skylight Health” or the “Company”), a healthcare platform combining technology and analytics focused on transitioning patients into value based care to drive better health outcomes and experiences in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares (the “Series A Preferred Shares”) for the month of February 2023. The Series A Preferred Shares trade under the “SLHGP” stock ticker symbol. In accordance with the terms of the Series A Preferred Shares, the Series A dividend will be payable in cash in the amount of $0.1927 per share on February 20, 2023 to the shareholders of record of the Series A Preferred Stock as of the dividend record date of January 31, 2023.

Skylight Health Announces Series A Preferred Stock Cash Dividend and Provides Update On The Previously Announced US$5 Million Financing

TORONTO, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SLHG; OTCQX: SLHGF) (“Skylight Health” or the “Company”), a healthcare platform combining technology and analytics, focused on transitioning patients into value-based care to drive better health outcomes and experiences in the United States, today announces the closing of the final tranche of the previously announced US$5 million financing in the form of convertible debentures (“Financing”).

Skylight Health Closes Final Tranche of Previously Announced US$5M Financing

TORONTO, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SLHG; OTCQX: SLHGF) (“Skylight Health” or the “Company”), a healthcare platform combining technology and analytics focused on transitioning patients into value based care to drive better health outcomes and experiences in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares (the “Series A Preferred Shares”) for the month of January 2023. The Series A Preferred Shares trade under the “SLHGP” stock ticker symbol.

Skylight Health Announces Series A Preferred Stock Cash Dividend

TORONTO, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SLHG; OTCQX: SLHGF) (“Skylight Health” or the “Company”), a healthcare platform combining technology and analytics, focused on transitioning patients into value-based care to drive better health outcomes and experiences in the United States, today announces that the Company has been granted an extension by the TSX Venture Exchange (the "TSXV") to complete the final tranche of the previously announced US$5 million financing in the form of convertible debentures (“Financing”) by no later than December 21, 2022.

Skylight Health Announces Extension of Final Tranche of Previously Announced US$5 million Financing

Revenue Growth of 152% Year over Year, 30% Growth Compared to the Previous Quarter, and Secures entry into Full-Risk Value-Based-Care in 2022 Revenue Growth of 152% Year over Year, 30% Growth Compared to the Previous Quarter, and Secures entry into Full-Risk Value-Based-Care in 2022

Skylight Health Group Reports Third Quarter 2022 Financial Results

TORONTO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SLHG; OTCQX:SLHGF) (“Skylight Health” or the “Company”); a healthcare platform combining technology, and analytics focused on transitioning patients into value-based care to drive better health outcomes and experiences in the United States, today announced that its financial results for the Third Quarter of 2022 will be released after the close of the market on November 16, 2022. The Company will host a conference call at 8:00am EDT on the morning of November 17, 2022, to discuss the financial results and outlook for the Company.

Skylight Health Announces Earnings Call and Corporate Update

TORONTO, Oct. 21, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SLHG; OTCQX: SLHGF) (“Skylight Health” or the “Company”), a healthcare platform combining technology and analytics, focused on transitioning patients into value-based care to drive better health outcomes and experiences in the United States, today announced a strategic commitment of USD 5 million in the form of a convertible debenture from a multi-billion dollar growth-oriented healthcare institutional investment firm in the United States. The investment is set to close in two tranches. The first tranche of USD 3.37 million has been completed as of the date of this release and the second tranche for the remaining USD 1.63 million is expected to close within 30 days.

Skylight Health Announces Strategic Investment from U.S. Institutional Healthcare Firm

News for Skylight Health Group Inc Stock (SLHGF)